<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Elderly Health Journal</title>
<title_fa>مجله سلامت سالمندان</title_fa>
<short_title>Elderly Health Journal</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ehj.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-6179</journal_id_issn>
<journal_id_issn_online>2423-6179</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>3</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effects of Different Coumarin- 3-Carboxamide Agents on Scopolamine Induced Learning and Memory Deficit in Mice</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-family:times new roman;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; It has been shown that three new synthetic coumarins-3-carboxamides including 3-fluorobenzilchloride, 4-fluorobenzilchloride and 2-hidroxy-3 metoxybenzaldehyde, have acetylcholinesterase inhibitory activity. This study was performed to estimate ameliorating effect of these new coumarin-3-carboxamides on memory impairments induced by scopolamine (1 mg/kg, induced prolongation) in mice.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-family:times new roman;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;strong&gt;Methods:&lt;/strong&gt; 30 male mice were divided into five groups, 6 mice in each group. Three experiment groups received coumarins-3- carboxamides (10 mg/kg body weight) 30 min before scopalamin injection and two other groups considered as normal (saline-treated) groups and finally one negative control (scopalamin only) group. The experiment groups were treated with coumarins of 3-fluorobenzilchloride, 4-fluorobenzilchloride and 2-hidroxy-3 metoxybenzaldehyde. The passive avoidance test was performed in an automatic conventional shuttle box set-up. The stepped down latency and number of errors was recorded.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-family:times new roman;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;strong&gt;Results:&lt;/strong&gt; With reference to saline-treated group, scopolamine-treated mice demonstrated impairment of learning and memory as a reduction of latency and an increased numbers of errors in step-down test)p &lt; 0.01). Treated mice receiving these coumarins at the dose of 10 mg/kg showed an increase in the number of avoidances on the memory tests compared to the scopolamine group (p &lt; 0.01).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-family:times new roman;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: The study has demonstrated some therapeutic effects of coumarin-3-carboxamides on learning and memory deficit induced by scopolamine. Further investigation is needed to explore whether coumarin-3-carboxamides could be beneficial for memory impairment in Alzheimer&amp;rsquo;s disease in which cholinergic deficit is one of the hallmarks.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Coumarins, Scopolamine, Passive Avoidance, 3-fluorobenzilchloride, 4-fluorobenzilchloride, 2-hidroxy-3 metoxybenzaldehyde</keyword>
	<start_page>50</start_page>
	<end_page>54</end_page>
	<web_url>http://ehj.ssu.ac.ir/browse.php?a_code=A-10-1-29&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Samaneh </first_name>
	<middle_name></middle_name>
	<last_name>Ghanei Nasab</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>s_ghaneinasab_chem@yahoo.com</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Chemistry, Arak Branch, Islamic Azad University, Arak, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Farzin</first_name>
	<middle_name></middle_name>
	<last_name>Hadizadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Azam </first_name>
	<middle_name></middle_name>
	<last_name>Marjani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Chemistry, Arak Branch, Islamic Azad University, Arak, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
